Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-10-30 Ring Christine Chief Legal Officer Option exercise +1,924 14,495
2023-10-30 Ring Christine Chief Legal Officer Option exercise +2,000 16,495
2023-10-30 Ring Christine Chief Legal Officer Option exercise · Restricted Stock Units −1,924 17,317
2023-10-30 Ring Christine Chief Legal Officer Option exercise · Restricted Stock Units −2,000 20,000
2023-10-30 Hansen Gwenn Chief Scientific Officer Option exercise +3,207 33,162
2023-10-30 Hansen Gwenn Chief Scientific Officer Option exercise +2,000 35,162
2023-10-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −3,207 28,861
2023-10-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −2,000 20,000
2023-07-31 van Houte Hans Chief Financial Officer Sale −1,245 $9.65 $12K 82,571
2023-07-31 Ring Christine General Counsel Sale −1,420 $9.65 $14K 12,544
2023-07-31 Hansen Gwenn Chief Scientific Officer Sale −1,884 $9.65 $18K 29,955
2023-07-30 van Houte Hans Chief Financial Officer Option exercise +2,886 81,816
2023-07-30 van Houte Hans Chief Financial Officer Option exercise +2,000 83,816
2023-07-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,886 28,861
2023-07-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,000 22,000
2023-07-30 Ring Christine General Counsel Option exercise +1,924 11,964
2023-07-30 Ring Christine General Counsel Option exercise +2,000 13,964
2023-07-30 Ring Christine General Counsel Option exercise · Restricted Stock Units −1,924 19,241
2023-07-30 Ring Christine General Counsel Option exercise · Restricted Stock Units −2,000 22,000
2023-07-30 Hansen Gwenn Chief Scientific Officer Option exercise +3,207 29,839

Page 24 of 32 · 632 trades